Nationwide 7-OH Law Tracker

KIODY • COMMUNITY TALKS

Have a question about your state?

Share a local hearing, ask about a law, or join the conversation with other readers.

Join the discussion →

Comments are reviewed before publication. Please include official sources when sharing legal updates.

Law and hearing update — October 21, 2026

Saratoga County, New York — adopted October 20; effective date pending verification. Resolution 308 adopted Local Law 7 of 2026, covering commercial sales and distribution of ordinary leaf, powder, capsules, extracts, concentrates, beverages, mitragynine, 7-OH and other kratom alkaloids. Personal possession is excluded. The law takes effect upon filing with the New York Secretary of State; filing has not been verified. The 30-day inventory-removal period does not authorize continued sales. Official adopted resolution, vote and law, pages 51–57.

Merrimack, New Hampshire — public hearing October 22, 7 p.m. Eastern / 5 p.m. Mountain. Proposed Chapter 195, Kratom Prohibition, will be heard in the Matthew Thornton Room, 8 Baboosic Lake Road. The draft prohibits extracts, enhanced or chemically modified products, capsules, tablets, liquids and drinks, with a narrow exception for unadulterated natural leaf and ground leaf for purchasers over age 21. Proposed effect upon passage; adoption is not verified. No remote testimony route or separate written-comment deadline has been verified. Official agenda · Draft and hearing notice.

Arlington, Washington — outcome pending official verification. October 19 council materials proposed a commercial sale, distribution and advertising ban covering botanical leaf, extracts, 7-OH and synthetic derivatives. Personal possession/use is excluded. The draft proposes November 18, 2026 as its effective date, but adoption and an executed ordinance have not been verified. Official proposal.

Expired opportunities: Iowa RA 26-323 / proposed rule 481—553.13 addressed adding MGPI, MGM-15 and MGM-16 to Schedule I; its October 20 hearing and 4:30 p.m. Central written-comment deadline have passed. These proposed additions do not themselves schedule botanical leaf or create a new 7-OH threshold. Official notice, pages 2231–2234. Edgecombe County, NC scheduled virtual comments October 20 at 7 p.m. Eastern on a proposed under-21 sales restriction and adulterated-product prohibition; the notice supplies no alkaloid thresholds, and adoption remains unverified. Official notice. Hillsborough County’s October 21 speaker-registration deadline has passed; A-5 sought authorization to advertise a tentative November 10 hearing, not enactment. Final action remains unverified.

These updates do not change Colorado law. This is a verified selection of developments, not a fresh verification of every state or locality. Older entries retain their review dates. Updated status above supersedes earlier pending-vote and open-deadline references below.

HEARING & MEETING UPDATE • OCTOBER 20, 2026

  • Saratoga County, NY: Local Law 7 adopted October 20 by Resolution 308; effective upon Secretary of State filing, which remains unverified. See October 21 update above.
  • Quincy, WA: October 20, 6 p.m. Pacific — council discussion, item J-4, following the October 6 hearing; not an enacted ban.
  • Hillsborough County, FL: October 21, 9 a.m. Eastern — draft review, A-5. Speaker signup closes at 9 a.m. Eastern that day. Proposed November 10, 10 a.m. Eastern hearing is conditional on approval. Draft distinguishes ordinary leaf from enhanced/concentrated products.
  • Warren County, NY: November 20, 10 a.m. Eastern — public hearing on proposed Local Law 9, including botanical leaf and extracts.

Hamilton County’s November 5 hearing and Tennessee’s November 10 rule hearing remain listed below. Ulster’s proposed November 17 hearing remains tentative; its earlier October 20 hearing-setting resolution was postponed.

Full hearing calendar, product scope, locations, participation instructions and official government sources

These out-of-state proposals do not change Colorado law. This is a verified selection, not a fresh review of every state or locality. Existing entries retain their own review dates.

Join Kratom Community Talks: October law updates and public hearing watch

NEWS & HEARING WATCH • OCTOBER 19, 2026

Federal notice published; proposed thresholds are not yet effective

DEA published revised notices on October 14. The 7-OH/MGPI proposal uses alternative triggers: either substance alone, or their combined amount, greater than 1 mg/g in solids or 1 mg/mL in liquids, OR a mitragynine-to-7-OH/MGPI mass ratio below 100:1. A temporary order cannot issue before November 13; that is not a guaranteed effective date. MGPI, MGM-15 and MGM-16 remain controlled under the August 26 order. Botanical leaf is not blanket-scheduled by this notice; below-threshold does not mean federally approved or safe.

DEA-1570 published notice · DEA-1644 published notice

State and local updates

  • Utah agency warning, October 5: Officials reported four deaths linked to products marketed as kratom or cat’s claw; testing identified MGPI and MGM-15. The notice distinguishes pure natural-leaf products from prohibited extracts and semi-synthetic chemicals. This is an enforcement/public-health warning, not a new threshold. Utah official warning.
  • Dutchess County, NY: The published adoption notice for Local Law 6 of 2026 targets concentrated/synthetic 7-OH and named derivatives while preserving adult access to natural leaf. Do not treat this as an all-leaf ban. Official adoption notice.
  • Pennsylvania: HB 2657 passed the House 202–0 on October 5 and was referred to Senate Health & Human Services on October 13. It remains a proposal, not current law; House passage alone creates no new sales or shipping restriction. Official bill history and current text.
  • Colorado: Bulletin 26-03, posted October 2, concerns kratom-containing alcohol beverages in licensed liquor commerce. It should not be described as a blanket ban on ordinary nonalcoholic leaf products. Official bulletin.

Public hearings and comment opportunities

Times below are local to the hearing. Check the official notice before attending; this is a verified selection, not an exhaustive national calendar.

  • Hamilton County, New York — November 5, 11 a.m. Eastern: Hearing on proposed Local Law 2 of 2026, covering kratom in all forms, at the Supervisors’ Chambers, County Offices, Lake Pleasant. The notice allows written communications to the Clerk. Official hearing notice and proposal.
  • Tennessee — November 10, 11–11:30 a.m. Central: Drug Free Workplace Programs rulemaking, Tennessee Room, 220 French Landing Drive 1A, Nashville. Proposal adds kratom to the program’s drug definition. Written comments to [email protected] are due November 24, 4:30 p.m. Central. Official hearing and comment instructions.
  • Ulster County, New York — November 17, 7:05 p.m. Eastern, proposed: Resolution 480.1 would set a hearing on Local Law 16 targeting concentrated/synthetic 7-OH. The official page still marks the resolution pending; confirm final scheduling before making plans. Official resolution and status.
  • Montgomery, New York — closed opportunity: The October 6 hearing and October 7 noon comment deadline have passed. The hearing notice alone does not establish enactment. Archived official notice.

Community discussion: Which local proposal affects your community? Share an official government link, bill or ordinance number, date and product scope. Separate personal experience from research findings; avoid private information and unsupported treatment claims. Kiody supports responsible adult botanical access, clear labels and product-specific rules.

Update log — October 19: confirmed October 14 federal publication; added current hearing/comment watch and dated state/local developments. Older state entries retain their own review dates. Educational information for adults 21+; not legal or medical advice. Kiody does not sell concentrated 7-OH.

Federal update reviewed: October 19, 2026. State/local entries retain their individual review dates. This tracker covers concentrated or enhanced 7-hydroxymitragynine products. For ordinary botanical leaf, see the Nationwide Kratom Leaf Law Tracker.

Protect Botanical Kratom Access

Botanical kratom leaf is not the same product as concentrated, enhanced, synthesized or semi-synthesized 7-OH. Kiody supports responsible access for adults 21+, honest labeling, independent testing and laws that preserve this distinction. Kiody does not sell concentrated 7-OH.

Public policy should be based on transparent evidence. We support disclosure of lobbying and financial conflicts, open public records and product-specific rules. We oppose blanket restrictions that erase the difference between traditional botanical leaf and manufactured high-potency products.

The former federal comment period closed September 10, 2026. See the current October federal update above; do not use an expired comment deadline as a current call to action.

Docket HHS-OASH-2026-0232. Civic information only; not legal advice. Do not include private medical or identifying information you do not want made public.

Verified law changes — September 4, 2026

Botanical leaf and concentrated 7-OH are tracked separately below. “Proposed” does not mean enacted. Kiody is 21+ and does not sell concentrated 7-OH.

  • Massachusetts — effective statewide prohibition: 105 CMR 726.000 took effect August 28, 2026. Its temporary Schedule I placement covers botanical Mitragyna speciosa, mitragynine, 7-OH, mitragynine pseudoindoxyl, MGM-15, MGM-16 and products held out as kratom. Massachusetts is blocked for all kratom shipments.
  • Albany County, New York — effective all-product sales and distribution ban: Emergency Public Health Order No. 1 took effect September 1; covered products had to be removed from public retail areas by 12:01 a.m. September 3. The county describes the restriction as covering all kratom products, including botanical leaf.
  • Nassau County, New York — effective categorical sales and distribution ban: Local Law 3 of 2026 became effective May 12 and expressly reaches online distributors. It covers botanical leaf, extracts and concentrated products; the reviewed law does not create a general personal-possession offense.
  • Mount Vernon, Washington — effective September 3: Ordinance 3945 prohibits sales, distribution, delivery and related advertising of botanical leaf, extracts, enhanced products and concentrated or synthesized 7-OH within incorporated Mount Vernon.
  • Salem, Massachusetts — local rule effective September 1: Board of Health Regulation 34 separately prohibits manufacturing, sale and distribution of kratom products. The broader Massachusetts statewide prohibition also applies.
  • Dare County, North Carolina — adopted August 3: Chapter 115 preserves a conditional 21+ channel for qualifying botanical leaf but prohibits synthetic, semi-synthetic, chemically converted and certain above-threshold 7-OH products. Online age verification, a 21+ delivery signature, labeling and a lot-specific accredited-lab COA are required. Apply the county rule only after confirming the delivery address is in covered unincorporated territory.
  • Kentucky — current 400 ppm rule and future commerce ban: 902 KAR 55:015 §1(2)(c), effective March 12, 2026, places 7-OH above 400 ppm (0.04%) by dry weight in Schedule I. This is a different calculation from Kentucky’s older 2%-of-total-alkaloids product limit. Enacted H.B. 757 / Acts Chapter 161 separately bars processor and retailer commerce in every kratom product beginning July 1, 2027 under the section-specific codified statutes; the published act and codified effective dates warrant legal review.
  • Clinton Township, Michigan — local 21+ rule: Ordinance 503 / Chapter 621, adopted January 26, prohibits providing kratom to anyone under 21 and requires identification and a retail notice. It is not a statewide adult botanical-leaf ban.
  • Iowa — advisory, not a new law: The Governor, HHS and Department of Public Safety issued a September 1 advisory. It did not itself create an age threshold, possession offense or shipping prohibition; H.F. 2133 remains unenacted.
  • Connecticut — corrected effective date: Final Rule 2026-003 / PR2025-018 became effective April 2, 2026; March 25 was the earlier product-removal deadline. The Schedule I rule covers botanical leaves, stems and extracts as well as separately listed 7-OH. Treat Connecticut as do not ship for every kratom product.
  • Bingham County, Idaho — proposal only: The county published a proposed kratom ordinance and held an August 28 hearing. The official webpage calls it Ordinance 2026-13 while the PDF says 2026-12. Enactment is not verified, so no current shipping restriction should be inferred from the proposal.
  • North Dakota — H.B. 1628 enacted September 4: The Governor signed H.B. 1628. Adults 21+ may possess qualifying pure leaf at or below 0.05% 7-OH dry weight, but all kratom sales remain prohibited until the Attorney General adopts rules and issues licenses. Future licensed commerce excludes extracts. Above-threshold 7-OH and named derivatives are Schedule I. Continue treating North Dakota as do not ship while licensing is unavailable.
  • New York proposals: These September proposal notes are archived. Current Menands and Rensselaer enactment/effective-date status requires fresh verification; do not rely on the earlier pending classification.

Shipping note: These are educational classifications, not legal advice. County and municipal restrictions require address-level verification; a ZIP code may cross jurisdictional boundaries.

This guide tracks 7-OH laws by state for products containing isolated, synthesized,
semi-synthesized, or concentrated 7-hydroxymitragynine, commonly
shortened to 7-OH. It does not treat trace, naturally occurring 7-OH in
ordinary kratom leaf as identical to a concentrated 7-OH tablet, gummy,
strip, powder, or liquid.

Kiody does not sell concentrated 7-OH products. This page is
maintained as an educational and regulatory reference for adults
21+.

This page is not legal advice, medical advice, or a statement
that any product is safe, approved, or appropriate for use.

Federal status — reviewed October 19, 2026

Proposed federal thresholds: either 7-OH or MGPI alone, or their combined amount when both are present, greater than 1 mg/g in solids or 1 mg/mL in liquids; alternatively, mitragynine mass divided by 7-OH, MGPI, or their combined mass below 100. These are proposed scheduling criteria, not safety limits. HHS October 9 recommendation.

See the dated notice at the top of this page for timing and existing controls. The earlier July threshold notice is being replaced; it should not be used as the current proposed threshold.

7-OH status key

  • Prohibited with leaf: The state prohibits kratom
    leaf and 7-OH.
  • 7-OH specifically controlled/prohibited: Leaf may
    remain available under separate rules, but concentrated 7-OH is
    prohibited or scheduled.
  • Threshold/cap applies: Only products within the
    state’s permitted composition limits may be sold.
  • No separate statewide control located: This does
    not mean FDA-compliant, safe, approved, or lawful in every product
    form.
  • Local restriction: A city or county rule may be
    stronger than statewide law.
  • Pending: Proposed legislation or rulemaking is
    shown separately from current law.

Fifty-state 7-OH matrix

State Concentrated 7-OH status Key distinction
Alabama Prohibited with leaf 7-OH is a Schedule I substance.
Alaska No separate statewide control located Federal and general product law still apply.
Arizona Threshold/cap; synthetic alkaloids prohibited 7-OH in the alkaloid fraction may not exceed the state limit.
Arkansas Prohibited with leaf 7-OH is controlled.
California Retail/manufacturing prohibition California agencies state that botanical kratom and 7-OH products for consumption are illegal to manufacture or sell. On September 2, 2026, the state reported 8,038 compliance visits, 181 violations, and 7,888 kratom or 7-OH products removed.
Colorado Concentrated/synthetic products prohibited or capped Current law distinguishes compliant botanical leaf from synthesized,
semi-synthesized, and above-limit products.
Connecticut Prohibited with leaf Final Rule 2026-003 / PR2025-018 became effective April 2, 2026. March 25 was the earlier product-removal deadline.
Delaware No separate statewide control located Verify current agency and local rules.
Florida Schedule I above product-specific triggers; 21+ leaf otherwise regulated More than 1 mg/g in solids, powders or capsules; more than 1 mg/mL in liquids; or a mitragynine-to-7-OH ratio below 100:1 by mass. 7-acetoxymitragynine, MGM-15 and MGM-16 are separately controlled.
Georgia Threshold/cap; synthetic products restricted Product-composition rules apply.
Hawaii No separate statewide control located Verify current agency and local rules.
Idaho No enacted statewide control located; local restrictions and proposal 2026 statewide bills were not enacted. Bingham County published a proposed ordinance and held an August 28 hearing, but enactment remains unverified; do not report the proposal as current law.
Illinois Local restrictions; statewide age rule for kratom Check county and municipality.
Indiana Prohibited with leaf State synthetic-drug law applies.
Iowa No new statewide control from September 1 advisory The joint Governor/HHS/DPS advisory is not legislation, a rule or a scheduling order. H.F. 2133 remains unenacted.
Kansas Prohibited with leaf Statewide Schedule I prohibition effective July 1, 2026.
Kentucky 7-OH above 400 ppm dry weight is Schedule I; all-product commerce ban begins July 1, 2027 Mitragynine remains expressly excluded from the current scheduling rule. Enacted H.B. 757 bars processor and retailer commerce in all kratom products beginning July 1, 2027 under the section-specific codified statutes; the published act displays a conflicting date requiring legal review.
Louisiana Prohibited with leaf Statewide prohibition effective August 1, 2025.
Maine No separate statewide control located Verify current agency and local rules.
Maryland Threshold/cap under regulated framework Verify exact product composition and current rule.
Massachusetts Temporary statewide Schedule I prohibition effective August 28, 2026 No concentration threshold applies under the emergency action; it covers 7-OH, mitragynine pseudoindoxyl, MGM-15, MGM-16, and botanical kratom forms.
Michigan No final statewide 7-OH prohibition; Clinton Township is 21+ Clinton Township Ordinance 503 broadly covers products represented as kratom but establishes an age rule, not a statewide concentration threshold or categorical adult ban.
Minnesota 21+ sale and possession rule; no 7-OH concentration threshold Effective August 1, 2026. Chapter 63 covers substances containing mitragynine or 7-OH but does not individually name mitragynine pseudoindoxyl, MGM-15, or MGM-16.
Mississippi Strict threshold/cap Not more than 1% of total alkaloids and not more than 0.5 mg per
container under the cited state definition.
Missouri Local concentrated-product bans Check destination city and county.
Montana No separate statewide control located Verify current agency and local rules.
Nebraska Threshold/cap under regulated framework Registration and product rules apply.
Nevada Threshold/cap under regulated framework Verify composition and labeling.
New Hampshire Local prohibitions Check destination municipality.
New Jersey No separate statewide control located Pending legislation is not law.
New Mexico No separate statewide control located Verify current agency and local rules.
New York State age/label rules plus categorical local bans and pending proposals Albany and Nassau Counties prohibit sales and distribution of all kratom products. The older Menands/Rensselaer proposal classification requires fresh enactment verification.
North Carolina Dare County product-specific restriction Chapter 115 preserves qualifying botanical leaf for adults 21+ but restricts synthetic, semi-synthetic, chemically converted and certain above-threshold 7-OH products. Online age verification and a 21+ delivery signature are required in covered territory.
North Dakota Pure leaf possession permitted for adults 21+; sales remain prohibited pending licensing H.B. 1628 was signed September 4, 2026 and takes effect upon filing. Pure leaf at or below 0.05% 7-OH dry weight may be possessed by adults 21+, but no kratom sales may occur until rules and licenses exist. Extracts are excluded from the future licensed market; above-threshold 7-OH, MGPI, MGM-15, MGM-16 and 7-acetoxymitragynine are Schedule I.
Ohio 7-OH and named derivatives are Schedule I; vegetation-form leaf is separately excluded The rule names 7-OH, mitragynine pseudoindoxyl, dihydro-7-hydroxy mitragynine (MGM-15), and 7-acetoxymitragynine. It provides no numeric safe harbor. MGM-16 is not individually named.
Oklahoma Threshold/cap under regulated framework Verify composition and label requirements.
Oregon Regulated product framework Verify processor registration, testing, and current composition
rule.
Pennsylvania No final statewide 7-OH law located KCPA proposals are not current law.
Rhode Island Thresholds apply in a licensed 21+ market; no retail-customer delivery Prohibited above 0.5 mg 7-OH per gram, above 1 mg per serving, or above 1% of total kratom alkaloids. Synthetic mitragynine, synthetic 7-OH, and other synthetically derived kratom compounds are prohibited.
South Carolina Threshold/cap under regulated framework 2026 repeal/ban bills are pending, not enacted.
South Dakota Threshold/cap under regulated framework Verify current composition and label provisions.
Tennessee Prohibited with all kratom effective July 1, 2026 No concentration exception. The state text does not individually enumerate mitragynine pseudoindoxyl, MGM-15, or MGM-16; the separate federal order still applies.
Texas Threshold/cap; synthetic products prohibited Verify the current statutory percentage and any enacted amendments
before shipment.
Utah Threshold/cap under regulated framework Registration, testing, and labels apply.
Vermont Prohibited with leaf 7-OH is a regulated drug.
Virginia 21+ threshold/cap framework effective July 1, 2026 Sale is prohibited above 1% 7-OH of total alkaloids in the container or above 1 mg 7-OH per serving. Synthesized, semi-synthetic, and synthetic kratom-like compounds are prohibited.
Washington No final statewide 7-OH law; Mount Vernon local categorical ban Mount Vernon Ordinance 3945 became effective September 3 and prohibits delivery and sale of concentrated, enhanced and synthesized 7-OH as well as botanical leaf within incorporated city limits.
West Virginia Regulated product framework Permits, age verification, and product rules apply.
Wisconsin Prohibited with leaf 7-OH is Schedule I.
Wyoming No final statewide prohibition located Proposed ban legislation is not law at last verification.

District of Columbia

7-OH is controlled in the District. Do not infer that the same rule
automatically prohibits every natural-leaf product without reviewing the
exact product and current District law.

Verified 7-OH legal changes

  • California: The September 2, 2026 enforcement report lists 8,038 compliance visits, 181 violations, a 97.75% compliance rate among ABC licensees, and 7,888 kratom or 7-OH products removed. It is an enforcement update, not a new law or effective-date change. California’s agency position continues to cover botanical kratom as well as 7-OH products and announces no numerical 7-OH exception.
  • Federal: October 9 updated notices replace the earlier threshold approach. The revised 7-OH/MGPI notice was published October 14; an actual later order is required. See the current update above.
  • Kentucky: 7-OH above 400 ppm dry weight is Schedule I; mitragynine is expressly excluded. HB 757 has section-specific codified commerce provisions beginning July 1, 2027; the act and codified dates warrant legal review.
  • Massachusetts: The temporary statewide action effective August 28, 2026 uses no concentration threshold and covers 7-OH plus named derivatives.
  • Minnesota: Chapter 63 established a 21+ rule effective August 1, 2026 but no 7-OH concentration threshold.
  • Ohio: The May 19, 2026 rule names 7-OH, mitragynine pseudoindoxyl, MGM-15, and 7-acetoxymitragynine as Schedule I while separately excluding qualifying vegetation-form leaf.
  • Rhode Island: The Kratom Act limits effective April 1, 2026 prohibit products above 0.5 mg 7-OH per gram, 1 mg per serving, or 1% of total kratom alkaloids, as well as synthetically derived kratom compounds.
  • Tennessee: Public Chapter 950 applies a no-threshold, all-kratom prohibition effective July 1, 2026.
  • Virginia: Chapter 595 limits 7-OH to no more than 1% of total alkaloids in the container and no more than 1 mg per serving, effective July 1, 2026. Both limits apply, and synthesized or semi-synthetic products are prohibited.

California Kratom and 7-OH Enforcement Update

Updated September 3, 2026. On September 2, California reported 8,038 compliance visits, 181 violations and 7,888 kratom or 7-OH products removed from store shelves. The reported compliance rate among Department of Alcoholic Beverage Control licensees was 97.75%. This is an agency-enforcement update, not a new bill, regulation, court order or effective-date change.

California agencies continue to state that foods, dietary supplements and medical drugs containing botanical kratom or 7-OH are illegal to manufacture or sell. The agency position does not create a 21+ exception or numerical 7-OH threshold. The September 2 report also does not create a new general personal-possession offense. Kiody treats California as a do-not-ship destination for kratom products intended for consumption, serves adults 21+ and does not sell concentrated 7-OH.

California agencies state that foods, supplements and medical drugs containing botanical kratom or 7-OH are illegal to manufacture or sell. State enforcement reported removing 7,888 kratom or 7-OH products by September 2, 2026. That position covers ordinary botanical kratom and 7-OH products; it is not limited to concentrated 7-OH. Kiody does not ship kratom products to California and does not sell concentrated 7-OH. See the Governor’s official report and ABC advisory.

Florida 7-OH Law: 1 mg/g, 1 mg/mL, 100:1 Ratio and Mandatory Labeling

Updated August 31, 2026. Florida Emergency Rule 2ER26-2 took effect August 18, 2026, supersedes 2ER26-1, and is scheduled to expire June 30, 2027. Under the rule, 7-OH is Schedule I when a solid, powder or capsule contains more than 1 mg per gram; when a liquid contains more than 1 mg per milliliter; or when the product’s mitragynine-to-7-OH ratio is below 100:1 by mass. 7-acetoxymitragynine, MGM-15 and MGM-16 are separately listed without a stated concentration exception.

Emergency Rule 5KER26-11 took effect August 24, 2026 and requires labels to disclose 7-OH concentration and the mitragynine-to-7-OH ratio. FDACS announced 60 days of enforcement discretion beginning August 25 for labeling violations only. Products that are controlled or adulterated remain subject to immediate stop-sale action. Florida remains 21+ for kratom sales and deliveries. See the FDACS enforcement notice and Florida’s 21+ statute.

A product cannot be treated as lawful ordinary leaf merely because it is labeled “kratom.” The exact solid, liquid or capsule must remain outside all three Florida triggers and contain none of the separately controlled derivatives. Mitragynine pseudoindoxyl is not individually named in 2ER26-2 but remains independently federally Schedule I. Kiody is 21+ and does not sell concentrated 7-OH.

Virginia 7-OH Law: Dual Limits Apply Since July 1, 2026

Updated September 4, 2026. Virginia H.B. 360, enacted as Chapter 595, took effect July 1, 2026. It prohibits selling or offering a kratom product if 7-hydroxymitragynine exceeds 1% of the total alkaloids in the container or 1 mg per serving. Either limit is independently controlling.

The law separately prohibits products containing synthesized material, a semi-synthetic alkaloid or a synthetic kratom-like compound. It does not ban every botanical-leaf product merely because naturally occurring or detectable 7-OH is present. Qualifying botanical leaf and extracts remain available in a regulated 21+ market, subject to ingredient disclosure, the prescribed warning, restricted retail access and child-appeal restrictions. The law regulates sales and offers for sale; it does not establish a general adult-possession ban or a categorical botanical-leaf shipping ban.

Review the enacted Chapter 595 text, Virginia Code § 59.1-200 update and the Virginia Department of Health overview. The enacted statute supplies the controlling effective date and thresholds. Mitragynine pseudoindoxyl, MGM-15 and MGM-16 are governed separately by the federal Schedule I order. Kiody serves adults 21+ and does not sell concentrated 7-OH.

Qualifying botanical kratom products may be sold to adults 21 and older. A product may not be sold if it exceeds either Virginia’s 1% 7-OH-of-total-alkaloids container limit or its 1 mg 7-OH-per-serving limit. Synthetic material, semi-synthetic alkaloids and synthetic kratom-like compounds are separately prohibited from sale.

7-OH tracker FAQs

Is 7-OH federally
banned nationwide right now?

As of the October 19 review, the October 14 notice remains a notice of intent. A later order cannot issue before November 13. MGPI, MGM-15 and MGM-16 remain temporarily Schedule I. Existing state and local restrictions remain separate.

Does a
7-OH ban automatically ban ordinary kratom leaf?

Not always. Florida, Kentucky, Ohio, Colorado, and other
jurisdictions distinguish compliant botanical leaf from concentrated,
synthesized, semi-synthesized, or above-threshold 7-OH products.

Does Kiody sell concentrated
7-OH?

No. Kiody’s public catalog does not include concentrated 7-OH
tablets, gummies, strips, or comparable products.

Why
include a tracker for a product Kiody does not sell?

Consumers, retailers, and policymakers often encounter confusing
headlines that use “kratom” and “7-OH” interchangeably. The tracker
provides dated primary sources and makes the legal distinction
visible.